We advised Auna on its U.S. IPO and NYSE listing

Davis Polk advised Auna, S.A. on its $360 million U.S. initial public offering of 30,000,000 Class A ordinary shares. The underwriters have an option to purchase up to an additional 4,500,000 Class A ordinary shares. The shares are listed on the New York Stock Exchange under the symbol “AUNA.” The offering is expected to close on March 26, 2024, subject to the satisfaction of customary closing conditions.

Auna is a Latin American healthcare company with operations in Mexico, Peru and Colombia, prioritizing prevention and concentrating on high complexity diseases that contribute the most to healthcare expenditures. Founded in 1989, Auna has built one of Latin America´s largest modern healthcare platforms, consisting of a horizontally integrated network of healthcare facilities and a vertically integrated portfolio of oncological plans and selected general healthcare plans.

The Davis Polk capital markets team included partners Maurice Blanco and Hillary A. Coleman and associates Claudia Carvajal Lopez and Marcos Sauquet Trías. The finance team included counsel James Vickers and associate José Miguel Fernández. Partner Adam Kaminsky provided executive compensation advice. Counsel Sarah E. Kim provided Investment Company Act advice. The tax team included partner Mario J. Verdolini and associate Charles Collier. Members of the Davis Polk team are based in the New York, São Paulo and Washington DC offices.